Passive Protection of Balb/c Mice Conferred by mAb Me-1 Against Infection with N. meningitidis Strain 608B
Groups . | . | Number of living mice after the bacterial challenge* . | . | % of survival (range)‡ . | ||
---|---|---|---|---|---|---|
24 h . | . | 72 h . | ||||
Me-1–injected mice§ | 29/30 | 23/30 | 76 | |||
(60–100) | ||||||
Control mice‖ | 10/30 | 9/30 | 30 | |||
(0–40) |
Groups . | . | Number of living mice after the bacterial challenge* . | . | % of survival (range)‡ . | ||
---|---|---|---|---|---|---|
24 h . | . | 72 h . | ||||
Me-1–injected mice§ | 29/30 | 23/30 | 76 | |||
(60–100) | ||||||
Control mice‖ | 10/30 | 9/30 | 30 | |||
(0–40) |
The mice were challenged with 1 ml of a suspension containing 1,000 CFU of N. meningitidis strain 608B, 4% mucin (Sigma), and 1.6% hemoglobin (Oxoid).
Combined results of three separate protection experiments. The range indicates the lowest and highest survival rates obtained.
600 μl of ascitic fluid containing mAb Me-1 were injected intraperitoneally 18 h before the bacterial challenge.
The mice in the control group received 600 μl of ascitic fluid containing unrelated mAb or phosphate buffered saline.